Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 ...

The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.

The U.S. Food and Drug Administration approved the pill version of Wegovy on December 22, marking the first FDA-approved ...

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...

Some are calling them “miracle drugs” that have changed the lives of millions of people. Scott Budman reports. Some are calling them "miracle drugs" that have changed the lives of millions of people.

The Wegovy pill is now available in the starting dose at pharmacies and telehealth platforms nationally, opening a new phase ...

The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to ...

Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now "broadly available ...

Amid rising consumer interest in the medication, food manufacturers and retailers are weighing up how to offer different ...

Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...